Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral Palsy

Sex: All

Ages: 4 Years – 12 Years

Healthy volunteers: No

Phase: PHASE4

Enrollment: 40

Sponsor: Gaziosmanpasa Research and Education Hospital

Location: Gaziosmanpasa Research and Education Hospital Istanbul Gaziosmanpaşa

Summary

The aim of this study is to investigate the effects of Botulinum Neurotoxin-A (BoNT-A) injection applied to spastic muscles on pain sensation and Selective Motor Control (SMC) in cases diagnosed with diplegic spastic Cerebral Palsy.

Eligibility Criteria

Inclusion Criteria: * Patients diagnosed with Cerebral Palsy * Between the ages of 4-12 * GMFCS (Gross Motor Function Classification System)1-4 * Patients who have received an appropriate indication for BoNT-A injection from an experienced physiatrist * Patients who have not had botulinum toxin administered in the last 6 months Exclusion Criteria: * Mental retardation * GMFCS 5 * Have an intrathecal baclofen pump for spasticity treatment or history of soft tissue and/or bone surgery * Underwent dorsal rhizotomy * Have an active infection or a localized skin infection at the injection site * Using aminoglycoside antibiotics * Contracture

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06583343). StuddyBuddy aggregates publicly available trial information.